IBC reviews a wide variety of research involving infectious agents.
The IBC ensures proper safety practices are followed.
NIH Guidelines require the IBC to review all research involving recombinant DNA molecules.
The IBC has been charged by Federal law with the planning and implementation of the campus Biosafety Program with a purpose to ensure the health and safety of all personnel working with biohazardous agents. The IBC makes certain that research conducted at the Institution is in compliance with the NIH Guidelines for Research Involving Recombinant DNA Molecules and the Select Agent Rule, drafts campus biosafety policies and procedures, and reviews individual research proposals for biosafety concerns.
The UNMC IBC meets on the second Thursday of each month at 2:30 p.m.